Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Comment by redrillon Nov 08, 2007 10:45am
431 Views
Post# 13775830

RE: makes no sense

RE: makes no senseIn my poor opinion, what makes no sense is a lot of conspiracy theories with people looking for a 'quick fix'. At present everyone seems to agree that this drug should be a home run. Is 6 to 12 monhs longer to realize your windfall that signifigant or would futher dilution through fund raising for phIII trial be more signifigant? Is waiting for the Roche decision for 6 months smarter or pushing ahead with trials, and stretching cash reserves, to get psoriasis application to market the wiser direction. My view would be towards the patient, less dilution, fiscally sound 6 month pause. If(when) Roche opts in, things will proceed as planned albeit 6 months later, on the off chance Roche declines then a dilution to raise capital either through share issue or new partnering agreement for Psoriasis indications will be in order. instant gratification isn't always the best track, especially in investing, if you,re day trading and 'gambleing' on this stock then I fully understand the distress. don't get me wrong,I'm as annoyed as anyone that we,re still watching this price drift lower(intially bought in at $4.50) but then so has the rest of the market and US investors(as well as most other) have bigger worries than a tiny Canadian Biotech outfit.
Bullboard Posts